News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,080 Results
Type
Article (41141)
Company Profile (256)
Press Release (662683)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (205391)
Career Advice (2065)
Deals (35589)
Drug Delivery (96)
Drug Development (81212)
Employer Resources (174)
FDA (16238)
Job Trends (15001)
News (346981)
Policy (32750)
Tag
Academia (2635)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49846)
ALS (89)
Alzheimer's disease (1385)
Antibody-drug conjugate (ADC) (124)
Approvals (16241)
Artificial intelligence (262)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11693)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (179)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (279)
Cancer (2260)
Cardiovascular disease (175)
Career advice (1729)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (19)
Clinical research (66059)
Collaboration (838)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2621)
CRISPR (40)
C-suite (243)
Cystic fibrosis (100)
Data (2209)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6485)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86804)
Editorial (37)
Employer branding (22)
Employer resources (148)
Events (112962)
Executive appointments (727)
FDA (17501)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (751)
Gene editing (104)
Generative AI (21)
Gene therapy (303)
GLP-1 (715)
Government (4446)
Grass and pollen (4)
Guidances (67)
Healthcare (18918)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2764)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (317)
IPO (16548)
IRA (40)
Job creations (3717)
Job search strategy (1471)
Kidney cancer (10)
Labor market (38)
Layoffs (473)
Leadership (20)
Legal (7955)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (306)
MASH (67)
Medical device (13455)
Medtech (13460)
Mergers & acquisitions (19587)
Metabolic disorders (686)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1923)
NextGen: Class of 2025 (6577)
Non-profit (4528)
Now hiring (39)
Obesity (365)
Opinion (210)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (150)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57692)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20583)
Phase II (29093)
Phase III (21669)
Pipeline (1204)
Policy (138)
Postmarket research (2569)
Preclinical (8782)
Press Release (68)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (248)
Rare diseases (378)
Real estate (6050)
Recruiting (66)
Regulatory (22424)
Reports (46)
Research institute (2395)
Resumes & cover letters (353)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (132)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (30)
Startups (3631)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (29)
Vaccines (689)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (17)
Date
Today (148)
Last 7 days (903)
Last 30 days (2612)
Last 365 days (32888)
2025 (10747)
2024 (35366)
2023 (40252)
2022 (51416)
2021 (55934)
2020 (54410)
2019 (46899)
2018 (35247)
2017 (32447)
2016 (31873)
2015 (37854)
2014 (31619)
2013 (26711)
2012 (28894)
2011 (29577)
2010 (27546)
Location
Africa (740)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38273)
Australia (6237)
California (6145)
Canada (2021)
China (525)
Colorado (267)
Connecticut (274)
Delaware (148)
Europe (82096)
Florida (913)
Georgia (212)
Idaho (58)
Illinois (537)
India (25)
Indiana (309)
Iowa (11)
Japan (163)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (897)
Massachusetts (4589)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1734)
New Mexico (29)
New York (1756)
North Carolina (971)
North Dakota (8)
Northern California (2682)
Ohio (210)
Oklahoma (14)
Oregon (34)
Pennsylvania (1376)
Puerto Rico (12)
Rhode Island (33)
South America (1120)
South Carolina (23)
South Dakota (1)
Southern California (2309)
Tennessee (101)
Texas (911)
United States (23211)
Utah (183)
Virginia (147)
Washington D.C. (61)
Washington State (553)
West Virginia (3)
Wisconsin (55)
704,080 Results for "paladin labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Endo’s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada.
January 22, 2024
·
7 min read
Press Releases
Paladin Pharma and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for Public Funding of XCOPRI® (cenobamate tablets)
April 14, 2025
·
6 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation
C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc, have partnered to launch a complimentary clinical testing program for the diagnosis of the T315I mutation in Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia patients in Canada.
June 12, 2023
·
2 min read
Press Releases
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
November 15, 2024
·
4 min read
Press Releases
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
April 1, 2025
·
21 min read
Press Releases
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
March 28, 2025
·
1 min read
Press Releases
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
January 23, 2025
·
5 min read
Press Releases
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
March 20, 2025
·
8 min read
Press Releases
Know Labs, Inc. Announces $300K Registered Direct Offering
December 13, 2024
·
4 min read
1 of 70,408
Next
